Penumbra Inc (PEN) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.043x

Based on the latest financial reports, Penumbra Inc (PEN) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($58.26 Million) by net assets ($1.36 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Penumbra Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Penumbra Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PEN liabilities breakdown for a breakdown of total debt and financial obligations.

Penumbra Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Penumbra Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
VERBUND AG
VI:VER
0.075x
Sinopac Financial Holdings Co Ltd
TW:2890
0.289x
Fox Corp Class B
NASDAQ:FOX
-0.060x
Solstice Advanced Materials, Inc
NASDAQ:SOLS
0.121x
Synnex Corporation
NYSE:SNX
0.173x
McCormick & Company Incorporated
NYSE:MKC
0.094x
KT&G Corp
KO:033780
0.030x
COLOPLAST SP.ADR 1/10 DK1
F:CBH
0.162x

Annual Cash Flow Conversion Efficiency for Penumbra Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of Penumbra Inc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Penumbra Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $1.15 Billion $168.48 Million 0.146x +77.31%
2023-12-31 $1.18 Billion $97.33 Million 0.083x +248.16%
2022-12-31 $998.86 Million $-55.66 Million -0.056x -659.43%
2021-12-31 $953.93 Million $9.50 Million 0.010x +119.11%
2020-12-31 $637.79 Million $-33.24 Million -0.052x -194.97%
2019-12-31 $485.61 Million $26.65 Million 0.055x -19.52%
2018-12-31 $422.42 Million $28.81 Million 0.068x +115.17%
2017-12-31 $400.41 Million $12.69 Million 0.032x +165.97%
2016-12-31 $266.55 Million $-12.81 Million -0.048x +49.85%
2015-12-31 $232.52 Million $-22.28 Million -0.096x -118.55%
2014-12-31 $-12.37 Million $-6.39 Million 0.516x +22.61%
2013-12-31 $-8.06 Million $-3.40 Million 0.421x --

About Penumbra Inc

NYSE:PEN USA Medical Devices
Market Cap
$12.76 Billion
Market Cap Rank
#1842 Global
#683 in USA
Share Price
$325.33
Change (1 day)
-0.35%
52-Week Range
$225.54 - $359.40
All Time High
$359.40
About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also… Read more